Follow the AMPLIFON share price and the full management transaction log of the company, a publicly traded company based in Italy. Shares are quoted on the IT market, under the oversight of Consob. Operating in the Health Care sector, AMPLIFON has recorded 127 insider filings. Market capitalisation: €3bn. The latest transaction was filed on 23 June 2026 (Other). Among the most active insiders: ENRICO VITA. All data is accessible without an account.
127
Insider Decl.
n/a
Thresholds
€69,326
3 ops.
Buy Volume
€11m
34 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AMPLIFON Buy (bullish), based on 16 analysts. Average price target: €13.44.
16Σ signal
Buys €69,326€11m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,819 of 29,024 companies
56.6
score / 100
Value
65
Quality
48
FCF yld9.8%
Earn yld3.0%
EV/EBITDA9.6x
ROE5.7%
Gross mgn53%
Net mgn3.8%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AMPLIFON is an Italian company specializing in hearing solutions, providing hearing aids and related services. It is listed on the Italian stock market, XMIL.